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Abstract
Objective: The level of T cell activation in untreated HIV disease is strongly and independently associated with risk of
immunologic and clinical progression. The factors that influence the level of activation, however, are not fully defined. Since
endogenous glucocorticoids are important in regulating inflammation, we sought to determine whether less optimal
diurnal cortisol patterns are associated with greater T cell activation.
Methods: We studied 128 HIV-infected adults who were not on treatment and had a CD4+ T cell count above 250 cells/ml.
We assessed T cell activation by CD38 expression using flow cytometry, and diurnal cortisol was assessed with salivary
measurements.
Results: Lower waking cortisol levels correlated with greater T cell immune activation, measured by CD38 mean fluorescent
intensity, on CD4+ T cells (r =20.26, p = 0.006). Participants with lower waking cortisol also showed a trend toward greater
activation on CD8+ T cells (r =20.17, p = 0.08). A greater diurnal decline in cortisol, usually considered a healthy pattern,
correlated with less CD4+ (r = 0.24, p = 0.018) and CD8+ (r = 0.24, p = 0.017) activation.
Conclusions: These data suggest that the hypothalamic-pituitary-adrenal (HPA) axis contributes to the regulation of T cell
activation in HIV. This may represent an important pathway through which psychological states and the HPA axis influence
progression of HIV.
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Introduction
Persistently elevated T-cell activation is now recognized as one
of the key pathogenic features of HIV infection. T cell activation
increases cell turnover, and the high level of T cell activation is
thought to be one of the factors leading to depletion of CD4+ T
cells [1]. Although both CD4+ and CD8+ T cell activation are
associated with disease progression, the association, somewhat
paradoxically, is strongest with CD8+ T cells. One possible
explanation for this finding is that activated CD4+ T cells undergo
apoptosis more rapidly, whereas activated CD8+ T cells tend
persist much longer, making CD8+ T cells a better marker of the
overall state of T cell activation [1]. After controlling for viral load,
the level of CD8+ T cell activation in untreated individuals is
independently associated with risk of disease progression, as
defined by rate of CD4+ T cell loss [2] and risk of developing an
AIDS defining complication or dying [3–6].
The factors influencing T cell activation in HIV infection have
not been fully identified. While some factors that may contribute
to the level of activation have been identified, such as infection
with co-pathogens and microbial translocation through damaged
gut mucosa [7], they do not fully explain the observed variability
in T cell activation between HIV-infected individuals.
The hypothalamic-pituitary-adrenal (HPA) axis regulates secre-
tion of glucocorticoids, endogenous hormones with potent anti-
inflammatory properties. While increased secretion of glucocorti-
coids in periods of acute stress may prevent excessive immune
activation chronic stress, may lead to decreased glucocorticoid
sensitivity and impairment in the ability of the HPA axis to
regulate the immune system [8]. We hypothesized that relative
dysregulation of the HPA axis, as measured by altered patterns of
diurnal glucocorticoid secretion, results in greater levels of T cell
activation in persons with HIV.
Normal HPA physiology results in a diurnal rhythm of cortisol
secretion characterized by a peak shortly after waking, a gradual
decline over the course of the day, and a nadir one hour after the
usual time of sleep [9]. This rhythm is often altered in persons
exposed to chronically stressful situations, resulting in elevated
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bedtime cortisol [10] and flatter diurnal slopes [10–13]. Flatter
diurnal cortisol slopes have also been reported to be associated
with depressive symptoms in population based studies [14].
Additionally, several studies show associations between severe
chronic psychological stress and low morning cortisol [15–18].
A potential role of the HPA axis in HIV pathogenesis is
supported by emerging observations linking stress and mood with
disease outcome in lentiviral infections. For example, severe
stressful life events, lack of social support, and chronic depressive
symptoms are associated with accelerated progression of HIV
[19,20]. Of note, in one of these studies, elevated morning cortisol
was associated with more rapid disease progression (18). Also, in
studies of rhesus monkeys, those inoculated with the simian
immunodeficiency virus (SIV) exhibited shorter survival when
exposed to stressful circumstances [21,22].
The association between psychological stress and mood and
HIV progression is thought to be mediated by molecular
messengers of the HPA axis and autonomic nervous system
(ANS), and prior research has identified pathways linking the
sympathetic nervous system to HIV pathogenesis [23,24].
Norepinephrine upregulates expression of CCR5 and CXCR4
receptors on lymphocytes, co-receptors for HIV cell entry, which
may enhance HIV replication [25]. Other studies in an SIV model
suggest that chronic stress can increase sympathetic nervous
system innervation of lymph nodes, which in turn causes increased
SIV replication [26,27].
While there is evidence linking the sympathetic nervous system
to accelerated progression of HIV, a clear mechanism linking the
HPA axis to disease progression has not been established [23,24].
We hypothesized that the HPA axis influences HIV disease
progression by altering the level of T cell activation. To test this
hypothesis, we investigated the relationship between the HPA axis
and T cell activation in untreated HIV infected persons with early
stage disease. Here, we describe the associations between these
factors, and present a model in which impaired function of the
HPA axis, as often seen in chronic psychological stress, contributes
to abnormal T cell activation and accelerated disease progression.
Methods
Ethics Statement
The study was reviewed and approved by the UCSF Committee
on Human Research. We obtained written informed consent from
all of the participants.
Study design and participants
We performed a cross-sectional study of the relationship
between glucocorticoids and T cell activation in HIV by analyzing
baseline data from HIV-infected individuals in the University of
California San Francisco Staying Well study. While participants
went on to an intervention stage, the data presented here were all
obtained prior to any study intervention. Inclusion criteria
included (1) HIV-1 seropositivity, (2) CD4+ T lymphocyte count
.250 cells/ml, (3) plasma HIV-1 RNA.100 copies/ml, (4)
antiretroviral therapy naive or untreated for at least four months,
and (5) 18 or more years of age. Exclusion criteria included a plan
to initiate antiretroviral therapy within 12 months from the time of
enrollment and current use or use in the past 6 months of
immunomodulator drugs.
Subjects were recruited in the San Francisco area through an
extensive recruitment network that included referrals from
physicians, community based organizations, other research
studies, and self referral generated by word of mouth, advertising,
and community outreach. The study received approval from the
UCSF Committee on Human Research, and all subjects gave
written informed consent.
Measures
We measured salivary cortisol by providing participants with a
home saliva collection kit and instructions to collect three saliva
samples each day over three days. In addition to providing a
practical means of measuring cortisol while subjects perform
normal daily activities, measurements of salivary cortisol more
accurately reflect serum free cortisol concentrations than do
measurements of serum total cortisol. The salivary cortisol
concentration is independent of salivary flow [28,29]. Participants
were instructed to collect the first sample immediately after
waking, the second sample at 30 minutes post-waking, and the
third sample immediately before bed. To ensure that the
30 minute post-waking sample was collected at the accurate time
interval from waking, participants were given a timer to set for
30 minutes upon waking in the morning to serve as a reminder.
Participants were also provided with a saliva logbook and
instructed to record their waking time, bedtime, and collection
times. Detailed instruction in sample collection was provided to
participants by trained staff.
Saliva samples were collected by having participants drool into
collection tubes, which were frozen and stored at 220 C until
analysis. Before biochemical analysis, samples were centrifuged at
3000 rpm for 5 minutes, resulting in a clear supernatant of low
viscosity. Free salivary cortisol was analyzed with a commercially
available chemi-luminescence-assay (CLIA) with a high sensitivity
of 0.16 ng/ml (IBM; Hamburg, Germany).
Blood was drawn between 8 am and noon, in acid citrate
dextrose venous vacuum collection tubes. Peripheral blood
mononuclear cells (PBMCs) were isolated from whole blood by
Ficoll-Hypaque density gradient centrifugation within 6 hours of
blood drawing, cryopreserved, and stored at the UCSF Biological
Specimen Bank.
Several immunophenotypic markers can be used to quantify T
cell activation in vivo, but CD38 expression on T cells is the
marker that has shown the best characterized ability to predict
disease progression in HIV [4]. CD38 is a multifactorial
transmembrane glycoprotein that is upregulated during T cell
activation and is associated with increased cell-to-cell adhesion,
increased levels of cytokine production, and more rapid CD4+ T
cell proliferation [2,30,31]. The prognostic significance of CD38
expression in the setting of HIV appears to be greatest when
measured as the mean density of molecules per cell, rather than
the percentage of cells expressing CD38, but the proportion of T
cells expressing both CD38 and HLA-DR also provides useful
prognostic information [6].
We measured expression of CD38 and HLA-DR on T cells at
the UCSF Core Immunology Laboratory using flow cytometry
and previously described methods that have been optimized and
validated for frozen PBMCs [32]. Frozen PBMCs were rapidly
thawed in warm media and counted on a Guava PCA (Millipore)
with the Viacount assay (Millipore). Cells were transferred to
plates and then washed and labeled with Aqua Amine Reactive
Dye (AARD, Invitrogen) to discriminate dead cells. Without
additional washing, cells were stained with the following fluores-
cently-conjugated monoclonal antibodies: CD3-Pacific Blue,
CD38-PE, HLA-DR-FITC, CD4-PE CY7, (all from BD Biosci-
ence), and CD8-QDot 605 (Invitrogen). In each experiment a
fluorescent-minus one control (FMO) was included for CD38 and
HLA-DR to determine the cut off for positive staining. Stained
cells were washed, fixed in 0.5% formaldehyde (Polyscience), and
held at 4 C until analysis (within 18 hours).
Cortisol and T Cell Activation
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Stained cells were run on a customized BD LSR II flow
cytometer and 100,000 to 200,000 lymphocytes were collected for
immunophenotyping. Data were compensated and analyzed using
Flow Jo (Tree Star) to determine the proportion of CD4+ and
CD8+ T cells expressing each of the T cell markers. Combinations
of markers were calculated in FlowJo using the Boolean gate
function (see Figure 1 for a typical flow cytometry dot plot that
illustrates gating strategy). The geometric mean of relative
fluorescence intensity, referred to as the mean fluorescence
intensity (MFI), was determined for CD38 on CD4+ and CD8+
T cells. This approach is similar to the Quantibrite approach [33],
but the relative fluorescence units were not converted to the
number of molecules per cell as multiple parameters were
analyzed simultaneously. Based on previous work showing that
CD38 antigen expression on CD8+ T cells is the strongest marker
of HIV disease progression to AIDS and death, we used CD38
MFI on CD8+ as our primary outcome measure [4].
Plasma specimens were used to measure HIV-1 RNA copies per
milliliter by polymerase chain reaction using the Amplicor HIV-1
Monitor Test, v1.5 (Roche Diagnostics).
Analysis
Raw cortisol data were screened for outliers thought to be due
to contamination (e.g. blood) or poor participant compliance;
samples with values $100 nmol/L were deleted. Sample 1
(waking sample) was excluded if collected .10 minutes after
waking, sample 2 (30 min post-waking sample) if collected
,20 minutes or.45 minutes after waking, and sample 3 (bedtime
sample) if collected later than 3 am the following day.
In addition to the cortisol variables representing specific time
points across the day, two derived cortisol variables were
calculated: the cortisol awakening response (CAR) and cortisol
slope. The CAR, or increase in cortisol from waking to 30 min
post-waking, was calculated as the difference score between
samples 1 and 2 (sample 2 – sample 1). The CAR typically
represents a 50% increase in cortisol levels and is larger in persons
experiencing chronic worry and stress [34]. The cortisol slope, or
degree of change (typically decline) in cortisol levels from early
morning to late evening, was computed as the difference between
samples 1 and 3 (sample 3 – sample 1). The slope is a global
measure of diurnal cortisol rhythmicity; flatter slopes are
associated with chronic stress, chronic fatigue, low socioeconomic
status, and low occupational status [10–13,16].
Averages were computed for each cortisol variable across the
three days of sample collection. Data for cortisol, viral load, and
CD4+ counts were positively skewed and normalized using a
logarithmic (log10) transformation. In computing derived variables,
raw variables were logarithmically transformed prior to other
calculations. Scatterplots were created and pairwise Pearson
correlation coefficients calculated to quantify the association
between cortisol predictor variables and immunologic outcome
variables. Multiple linear regression was used to model T cell
activation as a function of diurnal cortisol adjusted for age, viral
load, and CD4+ count. All analyses were performed using Stata
10.
Results
Of 177 participants enrolled in the overall study, 128 provided
adequate baseline specimens for both cortisol and immunologic
assays. Because Pearson correlation coefficients were calculated in
a pairwise fashion, and the number of missing datapoints differs
across variables, the number of participants used to calculate each
coefficient varies within a range of 101–128. The median CD4+ T
cell count at baseline was 469 cells/mm3 (IQR 372–585) and the
median plasma HIV RNA level was 4.3 log10 copies/mL (IQR
3.7–4.7) (Table 1).
As expected, CD4+ count was negatively correlated with
activation, as measured by CD38 MFI, on both CD4+
(r =20.18, p = 0.047) and CD8+ (r =20.20, p = 0.029) cells. Also
consistent with previous work, there was a positive correlation
between plasma HIV RNA levels and both CD4+ activation
(r = 0.33, p,0.001) and CD8+ activation (r = 0.48, p,0.001).
We next assessed T cell activation, measured by CD38 MFI, in
relationship to cortisol. We found that lower waking cortisol
correlated with greater CD4+ T cell activation (r =20.26,
p = 0.006) and a trend toward greater CD8+ T cell activation
(r =20.17, p = 0.08) (Table 2). In the multivariate regression
analysis, waking cortisol was a statistically significant predictor of
both CD4+ (b=2413 U/nmol/L, p = 0.001) and CD8+ activa-
tion (b=2542 U/nmol/L, p = 0.011) after adjustment for age,
CD4+ count, and viral load (Figure 2).
The 30 minute post-waking cortisol is typically the highest
cortisol value over the course of the day. In this study, lower
30 minute post-waking cortisol correlated with greater CD4+
activation (r =20.20, p = 0.049). This relationship was statistically
significant following adjustment for age, CD4+ count, and viral
load (b=2370 U/nmol/L, p = 0.015).
We also examined the relationship between diurnal cortisol
slope and T cell activation. Abnormal slope values (less negative or
positive) were correlated with greater CD38 MFI on both CD4+
(r = 0.24, p= 0.018) and CD8+ (r = 0.24, p= 0.017) cells. In
addition, cortisol slope was a statistically significant predictor of
CD4+ and CD8+ activation after adjusting for covariates (Figure 2).
Finally, we examined T cell activation as measured by the
percentage of T cells that were CD38+HLA-DR+. Table 3
summarizes the association between cortisol variables and the
percentage of CD4+/CD8+ cells with the CD38+HLA-DR+
phenotype. Greater bedtime cortisol was correlated with greater
Figure 1. Flow cytometry dot plot of activation markers on
CD8+ T cells. Representative dot plot depicting the use of CD38 and
HLADR markers to define activated CD8+ T cell populations. The red
numbers in each of corner represent the percentage of CD8+ T cells
considered to have each combination of the CD38 and HLA-DR markers.
For example, 60.6% of CD8+ T-cells in this plot were classified as being
positive for both CD38 and HLA-DR. A similar approach was used with
CD4+ T cells.
doi:10.1371/journal.pone.0063429.g001
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HLA-DR+CD38+CD8+%, but this relationship was not statisti-
cally significant in the multivariate regression analysis. There was
also a non-statistically significant trend toward flatter cortisol slope
predicting greater T cell co-expression of HLA-DR/CD38.
Overall, we found few associations between diurnal cortisol and
percentage of cells co-expressing activation antigens.
Discussion
Psychosocial stress and mood affect disease outcomes in
immune-related disorders such as HIV infection. Although some
potential pathways linking these psychological states to disease
progression have been identified (23), the mechanisms responsible
for this association require further elucidation. Given the strong
link between stress, mood, and the neuroendocrine system, we
examined whether altered cortisol patterns are associated with
greater T cell activation, a known risk factor for accelerated
progression of HIV. We found that lower morning cortisol and
flatter diurnal rhythms are associated with greater activation of
both CD4+ and CD8+ T cell subsets after adjustment for
covariates. To our knowledge, this is the first report of the
relationship between diurnal cortisol patterns and immune
activation in HIV+ subjects, and the results point to the HPA
axis as an important regulator of immune activation in persons
with HIV. These findings are particularly significant given the
importance of immune activation in the pathogenesis of HIV
infection, and imply that improvements in some of the stress-
related cortisol patterns could decrease immune activation during
HIV infection. Our findings add to an expanding literature
supporting a link between stress, the neuroendocrine system, the
immune system, and the overall risk of HIV disease progression.
The link between altered cortisol rhythmicity and greater
immune activation may be explained by a state in which immune
cells demonstrate impaired sensitivity to glucocorticoid signals, or
relative glucocorticoid resistance. Studies have shown that chronic
psychological stress correlates with impaired immune cell
responses to anti-inflammatory signals, including down-regulation
of glucocorticoid response elements in leukocytes [35,36]. These
results suggest a model in which chronic stress leads to relative
dysregulation of the HPA axis, which in turn causes reduced
sensitivity of immune cells to cortisol. Such a loss of sensitivity
would impair regulatory responses to dampen inflammation,
resulting in higher T cell activation and more rapid progression to
advanced disease. Of note, one of the HIV-1 accessory proteins,
vpr, has been reported to interact with the glucorticoid receptor
and enhance tissue sensitivity to glucocorticoids. This effect might
be expected to enhance the effect of normal diurnal variation of
cortisol on T-cell activation [37].
Our ability to draw conclusions from this study is limited by its
cross-sectional design. While our data show an association
between diurnal cortisol and T cell activation, we cannot presently
assert a causal relationship between predictor and outcome
variables. We suspect that the observed associations are driven
by the influence of glucocorticoids on immune function, but it is
also conceivable that HPA function is altered in the setting of
excessive immune activation. Furthermore, a bidirectional rela-
Table 1. Baseline descriptive statistics.
Characteristic Summary Statistic(s)
Sample size (n) 128
Age, median (10th–90th percentile) 40 (29, 55)
Male (%) 96.9
Race/ethnicity (%)
White 64.1
Black 7.8
Latino 16.4
Other 11.7
CD4 (CD4+ cells/mm3): median (10th–90th percentile) 469 (310, 786)
HIV (log10 plasma HIV-1 RNA copies/mL): median (10
th–90th percentile) 4.3 (3.2, 4.9)
T lymphocyte activation
CD4 T cell expression of CD38 (MFIa): median (10th–90th percentile) 954 (583, 1419)
CD8 T cell expression of CD38 (MFI): median (10th–90th percentile) 1099 (764, 2181)
HLA-DR+ CD38+ CD4+ T cell %b: median (10th–90th percentile) 8 (4, 15)
HLA-DR+ CD38+ CD8+ T cell %c: median (10th–90th percentile) 40 (24, 57)
Diurnal cortisol
Waking cortisol (nmol/L): median (10th–90th percentile) 13 (6, 24)
Waking +30 minute (nmol/L): median (10th–90th percentile) 17 (9, 27)
Cortisol awakening responsed (nmol/L): median (10th–90th percentile) 3 (25, 13)
Bedtime cortisol (nmol/L): median (10th–90th percentile) 3 (1, 14)
Cortisol slopee (nmol/L): median (10th–90th percentile) 210 (219, 21)
aMFI, or mean fluorescence intensity, is a measure of the density of cell surface antigen.
bPercent of CD4+ cells expressing HLA-DR and CD38 cell surface antigens.
cPercent of CD8+ cells expressing HLA-DR and CD38 cell surface antigens.
dCortisol awakening response is the increase in cortisol from waking to 30 minutes post-waking.
eCortisol slope is the decline in cortisol over the course of the day, from waking to bedtime.
doi:10.1371/journal.pone.0063429.t001
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tionship may exist. Data from prospective studies are needed to
elucidate the direction of this relationship. In addition, HIV-1
infection itself has also been linked to alterations in the HPA axis [38],
which suggests that HIV-1 may be influencing both T-cell activation
and the HPA-axis. Prior studies, however, have often reported
elevated basal cortisol in advanced infection, or adrenal insufficiency
in a subset of patients; our study focused on persons with earlier stage
infection and most patients had normal cortisol levels.
Figure 2. T cell activation as function of diurnal cortisol. The scatter plots show CD8 and CD4 activation as a function of waking cortisol or
diurnal cortisol slope. The slope presented in the graphs is the multivariate regression coefficient for T-cell activation as a function of cortisol
measures, adjusted for age, viral load, and CD4 count. Figure 2A shows CD38 mean fluorescent intensity (MFI) on CD8+ T cell in relationship to
waking cortisol. Figure 2B shows CD38 mean fluorescent intensity (MFI) on CD4+ T cell in relationship to waking cortisol. Figure 2C shows CD38 mean
fluorescent intensity (MFI) on CD8+ T cell in relationship to diurnal cortisol slope. Figure 2D shows CD38 mean fluorescent intensity (MFI) on CD4+ T
cell in relationship to diurnal cortisol slope. * = p,.05. ** = p#.001.
doi:10.1371/journal.pone.0063429.g002
Table 2. Correlations of T cell activation measures with cortisol measuresa.
Cortisol Measure CD38 on CD8+ T cell MFI CD38 on CD4+ T cell MFI
Waking cortisol 20.17 (20.35, 0.02), p = 0.08 20.26 (20.43, 20.08), p = 0.006
30 minute post-waking cortisol 20.08 (20.27, 0.11), p = 0.39 20.20 (20.37, 20.001), p = 0.049
Cortisol awakening responseb 0.10 (20.10, 0.28), p = 0.32 0.11 (20.09, 0.29), p = 0.28
Bedtime cortisol 0.14 (20.05, 0.32), p = 0.14 0.07 (20.12, 0.25), p = 0.50
Cortisol slopec 0.24 (0.04, 0.41), p = 0.017 0.24 (0.04, 0.41), p = 0.018
aThe values shown are pairwise Pearson correlation coefficients between cortisol measures ((log10 nmol/L) and cluster of differentiation (CD) 38 expression on T
lymphocytes, measured as mean florescent intensity (MFI), with 95 percent confidence intervals in parentheses, followed by P-values for the corresponding correlation
coefficients. The N used to calculate the coefficients is 101–109.
bCortisol awakening response was calculated by subtracting waking cortisol from 30 minute post-waking cortisol, and was typically positive.
cCortisol slope was calculated by subtracting waking cortisol from bedtime cortisol, and was typically negative.
doi:10.1371/journal.pone.0063429.t002
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Though the statistically significant correlations between diurnal
cortisol and immune activation are moderate, they are internally
consistent and may be biologically significant. From previous work
we know that immune activation in HIV is influenced by multiple
factors, including plasma HIV RNA levels, bacterial translocation
across altered gut mucosa, age, gender, and infection with co-
pathogens such as CMV [1]. We therefore do not expect
glucocorticoid levels to account for the majority of variance in
activation [2,39,40].
We chose to examine CD38 expression due to the evidence
supporting its importance in predicting HIV disease progression
[3–6]. While referred to as an indicator of T-cell activation, it is
also important to note that this is a molecule with multiple
functions, and not a pure activation marker. In this regard, the
relationship that we have shown between cortisol measures and
CD38 expression may not represent an association with immune
activation alone.
As with most studies of basal cortisol, this study relies on self-
report of times when measurements were taken and the relationship
between measurement and waking time. To the extent that cortisol
patterns truly influence T cell activation, this limitation is likely to
cause noise in our predictor variable and underestimation of the
true relationship. Some relationships in which we observed trends
towards associations, such as increased cortisol awakening response
and CD38 MFI on CD4+ and CD8+ T-cells, might not be
statistically significant in part due to variability in the collection time
of the 30 minute post-waking specimen. We invested considerable
effort, however, to minimize errors in the data by screening all
cortisol data for participant non-compliance and contacting
participants to clarify sampling times when necessary. Given the
widths of our confidence intervals and the care with which sampling
was performed, we believe the lack of statistical significance in some
of the hypothesized relationships does not rule out meaningful
associations between particular measures of diurnal cortisol and T
cell activation, but suggests that any actual associations are likely to
be variable and/or of modest strength.
The most unexpected finding in our study was the apparent
difference in the associations between cortisol and our two
measures of T cell activation (the density of CD38 on T cells
versus the frequency of T cells co-expressing CD38/HLA-DR).
There was a consistent association between the density of CD38
on T cells and diurnal cortisol rhythms, but similar associations
appeared to be absent (though with some overlap in confidence
intervals) between the percentage of cells expressing CD38/HLA-
DR and cortisol. This contrast underscores the difference between
relative mean fluorescence intensity and percentage measurements
for quantifying levels of activation. Glucocorticoids may have
more influence on the degree of immune activation than on the
percentage of cells in an activated state.
In conclusion, we have shown that cortisol patterns reflective of
chronic stress (less diurnal decline, low waking cortisol) were correlated
with greater T cell activation in the setting of HIV-1 infection. If
supported by further data, these findings indicate a pathway through
which psychological states and the HPA axis influence immune
function in HIV and other immune-mediated diseases.
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